Inactive Instrument

Genkyotex SA.

GKTX

FR0013399474

Biotechnology & Medical Research

Genkyotex SA(ENXTPA:GKTX) dropped from Next Biotech Index

October 05, 2021 at 09:30 am IST

Genkyotex SA has been removed from Next Biotech Index.

Latest news about Genkyotex SA.

Calliditas Therapeutics : Acquires Remaining Stake in Genkyotex	07/21/07	MT
Genkyotex SA(ENXTPA:GKTX) dropped from CAC AllShares Index	05/21/05	CI
Genkyotex SA(ENXTPA:GKTX) dropped from Next Biotech Index	05/21/05	CI
Global markets live: Sanofi, ASML, Apple, United Airlines, Netflix...	29/21/29
Global markets live: Airbnb, Coinbase, Walt Disney,...	14/21/14
Genkyotex Sa Reports Earnings Results for the Full Year Ended December 31, 2020	18/21/18	CI
Genkyotex : Chief Medical Officer Steps Down Amid Start of Phase 2/3 Study in Chronic Liver Disease	22/21/22	MT
Genkyotex SA Announces Update for Near Term Clinical Development Plan for Setanaxib	22/21/22	CI
Genkyotex : Reports Positive Results from Phase One Trial of Anti-fibrosis Drug Setanaxib	18/21/18	MT
Genkyotex Announces Positive Phase 1 Results Demonstrating Favorable Safety and Pharmacokinetic Profile of High-Dose Setanaxib	18/21/18	CI
Calliditas Therapeutics AB (OM:CALTX) completed the acquisition of 37.3% stake in Genkyotex SA.	11/20/11	CI
Genkyotex : Setanaxib Obtains Orphan Drug Designation By European Commission	08/20/08	MT
Genkyotex Announces Board and President Changes	03/20/03	CI
Genkyotex Sa Reports Earnings Results for the Half Year Ended June 30, 2020	17/20/17	CI
Genkyotex Announces the Enrollment of the 1st Patient in the Phase 2 Trial of Setanaxib in Idiopathic Pulmonary Fibrosis	14/20/14	CI
Calliditas Therapeutics AB (OM:CALTX) made a tender offer to acquire 37.3% stake in Genkyotex SA for €12.1 million.	13/20/13	CI
Genkyotex Announces the Dosing of the First Subjects in Its Phase 1 Study with High-Dose Setanaxib	30/20/30	CI
Genkyotex Provides New Clinical Data from the PBC Phase 2 Trial Providing Further Evidence of the Anti-Fibrotic Activity of Setanaxib	18/20/18	CI
Genkyotex Receives Approval From the French Medicines Agency to Initiate a Phase 1 Clinical Study With High-dose Setanaxib	13/20/13	CI
Genkyotex SA Announces Consolidated Earnings Results for the Year Ended December 31, 2019	05/20/05	CI
Certain Common Shares of Genkyotex SA are subject to a Lock-Up Agreement Ending on 3-MAY-2020.	03/20/03	CI
Genkyotex’s Setanaxib Significantly Improves Immunotherapy Including Checkpoint Inhibitors in Multiple Preclinical Cancer Models	03/20/03	CI
Genkyotex Sa Reports Earnings Results for the Full Year Ended December 31, 2019	27/20/27	CI
Genkyotex Reports Progress of Setanaxib Phase 2 Investigator Initiated Trials	03/19/03	CI
Genkyotex Announces FDA Approval of Phase 2 Investigator-Initiated Trial with GKT831 in IPF	17/19/17	CI

GenKyoTex SA is a France-based company involved in the biotechnology sector. The Company focuses on the development of therapies based on selective inhibition of nicotinamide adenine dinucleotide phosphate oxidase (NOX) enzymes, which cause a range of disease processes, such as fibrosis, inflammation, pain processing, cancer development and neurodegeneration. The Company's pipeline includes GKT831, a NOX inhibitor aimed at primary biliary cholangitis (PBC) and fibrosis; GKT771, a NOX inhibitor mainly aimed at inflammatory pain and angiogenesis, and other NOX inhibitors, which target at central nervous system (CNS), hearing loss and oncology.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+1.77%	42.75B
LONZA GROUP AG	+47.70%	41.61B
MODERNA, INC.	+12.24%	41.34B
CELLTRION, INC.	-8.83%	26.59B
ICON PUBLIC LIMITED COMPANY	+7.44%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-23.01%	18.12B
MEDPACE HOLDINGS, INC.	+30.56%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.82%	11.76B
UNITED THERAPEUTICS CORPORATION	+8.35%	11B

Other Biotechnology & Medical Research

Genkyotex SA.

Equities

GKTX

FR0013399474

Biotechnology & Medical Research

Genkyotex SA(ENXTPA:GKTX) dropped from Next Biotech Index

Latest news about Genkyotex SA.

Chart Genkyotex SA.

Company Profile

Sector Other Biotechnology & Medical Research